Methicillin-resistant Staphylococcus aureus in horses and horse personnel: An investigation of several outbreaks

Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, PO Box 80165, 3508 TD Utrecht, Utrecht University, The Netherlands.
Veterinary Microbiology (Impact Factor: 2.73). 09/2009; 141(1-2):96-102. DOI: 10.1016/j.vetmic.2009.08.009
Source: PubMed

ABSTRACT At the Veterinary Microbiological Diagnostic Center, the Netherlands, the percentage of methicillin-resistant Staphylococcus aureus (MRSA) isolates found in equine clinical samples increased from 0% in 2002 to 37% in 2008. MRSA of spa-type t064, belonging to MLST ST8 and spa-types t011 and t2123, both belonging to the livestock-associated MLST ST398, predominated. During an outbreak of post-surgical MRSA infections in horses at a veterinary teaching hospital in 2006/2007, MRSA isolates of spa-type t2123 were cultured from 7 horses and 4/61 personnel which indicated zoonotic transmission. After intervention the outbreak stopped. However, another outbreak occurred in 2008, where 17 equine MRSA isolates of spa-type t011 (n=12), t2123 (n=4), and t064 (n=1) were found. This time, 16/170 personnel were positive for MRSA with spa-type t011 (n=11) and t2123 (n=5). Personnel in close contact with horses were more often MRSA-positive (15/106) than those without (1/64). Screening of horses upon admission showed that 9.3% were MRSA-positive predominantly with spa-type t011. Weekly cross-sectional sampling of all hospitalized horses for 5 weeks showed that 42% of the horses were MRSA-positive at least once, again predominantly with spa-type t011, which suggests that nosocomial transmission took place. Fifty-three percent of the environmental samples were MRSA-positive, including samples from students' and staff members' rooms, and all were spa-type t011. This indicates that humans contribute to spreading the organism. Culturing of samples employing high-salt pre-enrichment performed better than a comparable method without pre-enrichment. Our results show that nosocomial transmission occurs in equine clinics and suggests that personnel play a role in the transmission.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Antimicrobials are essential medicines for the treatment of many microbial infections in humans and animals. Only a small number of antimicrobial agents with new mechanisms of action have been authorized in recent years for use in either humans or animals. Antimicrobial resistance (AMR) arising from the use of antimicrobial agents in veterinary medicine is a concern for public health due to the detection of increasing levels of resistance in foodborne zoonotic bacteria, particularly gram-negative bacteria, and due to the detection of determinants of resistance such as Extended-spectrum beta-lactamases (ESBL) in bacteria from animals and in foodstuffs of animal origin. The importance and the extent of the emergence and spread of AMR from animals to humans has yet to be quantified. Likewise, the relative contribution that the use of antimicrobial agents in animals makes to the overall risk to human from AMR is currently a subject of debate that can only be resolved through further research. Nevertheless, risk managers have agreed that the impact on public health of the use of antimicrobials in animals should be minimized as far as possible and a variety of measures have been introduced by different authorities in the EU to achieve this objective. This article reviews a range of measures that have been implemented within European countries to reduce the occurrence and the risk of transmission of AMR to humans following the use of antimicrobial agents in animals and briefly describes some of the alternatives to the use of antimicrobial agents that are being developed. © 2015 John Wiley & Sons Ltd.
    Journal of Veterinary Pharmacology and Therapeutics 04/2015; DOI:10.1111/jvp.12226 · 1.32 Impact Factor
  • Source
  • [Show abstract] [Hide abstract]
    ABSTRACT: The aims of this study were (1) to evaluate the antibacterial effects of equine platelet concentrates (PCs) and other blood-derived preparations on methicillin-resistant Staphylococcus aureus (MRSA); (2) to determine the effect of MRSA on the concentration of transforming growth factor beta 1 and platelet-derived growth factor BB over time; and (3) to determine the correlations between MRSA growth and blood cell counts (platelets and leukocytes), as well as growth factor (GF) concentrations, in PCs and other blood-derived preparations. Blood from 14 clinically healthy horses was used to prepare the different blood-derived preparations. Bacterial growth was significantly inhibited by the different PCs and the cell-free plasma products, mainly during the first 8 hours. Growth factor concentrations were not significantly affected by the presence of bacteria. No correlation between MRSA growth inhibition and blood cells and/or GFs was found. The in vitro bacteriostatic effect of PCs on MRSA could be predominantly attributed to the plasma complement.
    Journal of Equine Veterinary Science 03/2015; 35(3). DOI:10.1016/j.jevs.2015.01.001 · 0.89 Impact Factor

Full-text (2 Sources)